Documentos relacionados

1. Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice.
2. [Diabetes mellitus: endothelial dysfunction and changes in hemostasis].
3. [The treatment of diabetes mellitus: myths and evidence].
4. [Laboratory investigations in clinical diabetic practice].
5. [Epidemiology of diabetes mellitus: prevalence, incidence, pathogenesis, and prognosis].
6. Type 1 diabetes induced by immune checkpoint inhibitors.
7. Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity.
8. [Type 1 diabetes mellitus: most recent advances in its pathogenesis and treatment].
9. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment].
10. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.